An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins. Mar 2008 - Int. J. Oncol.; 32(4):1019-6439 [PMID:18360705] [Aigner M] [Janke M] [Lulei M] [Beckhove P] [Fournier P] [Schirrmacher V]
A tumor vaccine containing anti-CD3 and anti-CD28 bispecific antibodies triggers strong and durable antitumor activity in human lymphocytes. Dec 2005 - Int. J. Cancer; 118(3):0020-7136 [PMID:16108015] [Haas C] [Lulei M] [Fournier P] [Arnold A] [Schirrmacher V]
T-cell triggering by CD3- and CD28-binding molecules linked to a human virus-modified tumor cell vaccine. Mar 2005 - Vaccine; 23(19):0264-410X [PMID:15752830] [Haas C] [Lulei M] [Fournier P] [Arnold A] [Schirrmacher V]
